KALA BIO, Inc.

Healthcare · Biotechnology · United States

Last price 0.1655 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.20M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment. Its platform intends to utilize the KPI-012 clinical development dataset as a proof-of-concept validation environment, as well as the mesenchymal stem cell secretome (MSC-S) and persistent corneal epithelial defects (PCED) research for agent...